CID 53481208

Ganglioside gq1c (d18:0/12:0)

Structural Information

Molecular Formula
C101H173N5O55
SMILES
CCCCCCCCCCCCCCC[C@H]([C@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O[C@@]5(C[C@@H]([C@H](C(O5)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)C(=O)O)O)CC(=O)C)O[C@@]6(C[C@@H]([C@H](C(O6)[C@@H]([C@@H](CO)O[C@@]7(C[C@@H]([C@H](C(O7)[C@@H]([C@@H](CO)O[C@@]8(C[C@@H]([C@H](C(O8)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)C(=O)O)O)NC(=O)C)O)C(=O)O)O)NC(=O)C)O)C(=O)O)O)O)O)NC(=O)CCCCCCCCCCC)O
InChI
InChI=1S/C101H173N5O55/c1-8-10-12-14-16-18-19-20-21-23-24-26-28-30-53(120)52(106-66(127)31-29-27-25-22-17-15-13-11-9-2)45-146-91-78(135)77(134)82(64(43-113)149-91)152-93-80(137)89(83(65(44-114)150-93)153-90-51(32-46(3)115)81(73(130)60(39-109)147-90)151-92-79(136)88(74(131)61(40-110)148-92)160-100(96(142)143)35-56(123)68(103-48(5)117)85(157-100)72(129)59(126)38-108)161-101(97(144)145)36-57(124)70(105-50(7)119)87(159-101)76(133)63(42-112)155-99(95(140)141)34-55(122)69(104-49(6)118)86(158-99)75(132)62(41-111)154-98(94(138)139)33-54(121)67(102-47(4)116)84(156-98)71(128)58(125)37-107/h51-65,67-93,107-114,120-126,128-137H,8-45H2,1-7H3,(H,102,116)(H,103,117)(H,104,118)(H,105,119)(H,106,127)(H,138,139)(H,140,141)(H,142,143)(H,144,145)/t51-,52+,53-,54+,55+,56+,57+,58-,59-,60-,61-,62-,63-,64-,65-,67-,68-,69-,70-,71-,72-,73+,74+,75-,76-,77-,78-,79-,80-,81-,82-,83+,84?,85?,86?,87?,88+,89-,90+,91-,92+,93+,98-,99-,100+,101+/m1/s1
InChIKey
PRXZEZLIUMABNY-NZDASISNSA-N
Compound name
(2S,4S,5R)-5-acetamido-2-[(2R,3R,4S,5S,6R)-2-[(2S,3R,4R,5R,6R)-2-[(2R,3S,4R,5R,6S)-4-[(2S,4S,5R)-5-acetamido-6-[(1S,2R)-2-[(2S,4S,5R)-5-acetamido-6-[(1S,2R)-2-[(2S,4S,5R)-5-acetamido-2-carboxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy-1,3-dihydroxypropyl]-2-carboxy-4-hydroxyoxan-2-yl]oxy-1,3-dihydroxypropyl]-2-carboxy-4-hydroxyoxan-2-yl]oxy-6-[(2R,3S,4R,5R,6R)-6-[(2S,3R)-2-(dodecanoylamino)-3-hydroxyoctadecoxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

2336.0894 Da
Monoisotopic Mass

-5.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2337.0967 450.4
[M+Na]+ 2359.0786 445.3
[M-H]- 2335.0821 467.2
[M+NH4]+ 2354.1232 448.9
[M+K]+ 2375.0526 439.3
[M+H-H2O]+ 2319.0867 436.0
[M+HCOO]- 2381.0876 445.0
[M+CH3COO]- 2395.1033 442.4
[M+Na-2H]- 2357.0641 480.4
[M]+ 2336.0889 413.0
[M]- 2336.0899 413.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.